Invivyd (IVVD) Net Equity Issued and Repurchased (2021 - 2025)
Invivyd (IVVD) reported Net Equity Issued and Repurchased of $128.49 million for Q4 2025, compared with $135,000 a year earlier.
Analysis
Invivyd (IVVD) Net Equity Issued and Repurchased (2021 - 2025) Analysis & Trends
For FY2025, Invivyd posted Net Equity Issued and Repurchased of $182.53 million.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of 7.1% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $420,000 in FY2024 (-56.0%), $955,000 in FY2023 (+255.0%), $269,000 in FY2022 (-99.9%) and $335.16 million in FY2021 (+158.7%).
- The Q4 2025 figure ranks as the highest quarterly Net Equity Issued and Repurchased since Q2 2021.
- Year over year, Net Equity Issued and Repurchased gained in 1 of the last six quarters, with an average decline of 12.4%.
- The high point for year-over-year Net Equity Issued and Repurchased in five years was Q1 2023 (growth of 876.6%); the low point was Q2 2022 (a decline of 100.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Invivyd | 256.44 Mn | -250.20 Mn | 13.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 128.49 Mn |
| Sep 30, 2025 | 53.93 Mn |
| Jun 30, 2025 | 78,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Dec 31, 2024 | 135,000.00 |
| Sep 30, 2024 | 97,000.00 |
| Jun 30, 2024 | 99,000.00 |
| Mar 31, 2024 | 89,000.00 |
| Dec 31, 2023 | 246,000.00 |
| Sep 30, 2023 | 35,000.00 |
| Jun 30, 2023 | 215,000.00 |
| Mar 31, 2023 | 459,000.00 |
| Dec 31, 2022 | 49,000.00 |
| Sep 30, 2022 | 97,000.00 |
| Jun 30, 2022 | 76,000.00 |
| Mar 31, 2022 | 47,000.00 |
| Sep 30, 2021 | -101,000.00 |
| Jun 30, 2021 | 335.26 Mn |
API Access
Invivyd Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IVVD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "IVVD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IVVD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();